← Back to Search

Educational Intervention for Colorectal Cancer Screening

N/A
Waitlist Available
Led By Clement K Gwede, PhD, MPH, RN, FAAN
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between 45 and 75 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, immediately following intervention, at 3 months and at 6 months
Awards & highlights

Study Summary

This trial is testing educational materials about colorectal cancer screenings and the USPSTF recommendations.

Who is the study for?
This trial is for English or Spanish speakers living in the Tampa Bay area (Hillsborough, Pinellas, Polk, or Pasco county), aged between 45 and 75 years old who can consent to participate. It's not open to those outside this age range or location.Check my eligibility
What is being tested?
The study provides educational materials about colorectal cancer and screening based on US Preventive Services Task Force recommendations. The goal is to see if these interventions increase awareness and screenings among participants.See study design
What are the potential side effects?
Since this trial involves an educational intervention rather than a medical treatment, there are no direct physical side effects expected from participating.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 45 and 75 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, immediately following intervention, at 3 months and at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, immediately following intervention, at 3 months and at 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening

Trial Design

1Treatment groups
Experimental Treatment
Group I: Educational Intervention and Referral for Fecal Immunochemical Test (FIT) Kit or ColonoscopyExperimental Treatment1 Intervention
The Community Health Educator (CHE) will provide online, phone or in-person colorectal cancer (CRC) early detection, prevention, and screening education to increase knowledge of CRC and the importance of screening. These sessions will be conducted in small in-person sessions, virtually within a group, virtually via a self-paced/self-directed online learning module, or one-on-one via phone. Additionally, the CHE will provide information regarding FIT kit and colonoscopy screening and the screening process for attendees. The CHE and research assistant will be prepared to provide access to screening resources and services through participants' existing coverage. Those participants who do not have a primary care provider will be provided information on obtaining FIT kits through the mechanisms of the Federally Qualified Health Center (FQHC) and/or a colonoscopy through the cancer center on a case by case basis.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Educational Intervention
2013
N/A
~7220

Find a Location

Who is running the clinical trial?

H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
547 Previous Clinical Trials
135,424 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,717 Previous Clinical Trials
40,953,133 Total Patients Enrolled
Clement K Gwede, PhD, MPH, RN, FAANPrincipal InvestigatorMoffitt Cancer Center
2 Previous Clinical Trials
139 Total Patients Enrolled

Media Library

Educational Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05064410 — N/A
~23 spots leftby Jul 2025